doi: 10.1159/000375530 142 NazMSGTehraniFRMajdHAAhmadiFOzgoliGFakariFRet al
VerretLMannEOHangGBBarthAMCobosIHoKet al
,
In a combined analysis of three trials with 1,119 participants, individuals with PAM variants responded less effectively to GLP-1 drugs and were less likely to reach target HbA1c levels, a measure of long-term blood sugar control
In this exclusive report, Cure, a healthcare innovation ecosystem in New York City, and the Deerfield Institute unveil the results of a specialty physician survey, shedding light on their current prescribing of GLP-1RA medications, the challenges they face, and their expectations for future clinical applications of these drugs
The comparison between semaglutide and tirzepatide becomes relevant here, as the two medications may produce different rates of weight loss in different individuals, and choosing the one that produces a more gradual trajectory could be hair-protective